Clinical Challenges in HIV Treatment and Prevention
  • CME
  • CE

Moderated by Princy N. Kumar, MD, a panel of HIV experts discusses how the newest evidence on preventive medicine guides managing HCV sexual transmission in a young MSM on PrEP, prescribing PrEP for a male PWID and his female partner, and reducing cardiovascular risk in a middle-aged woman with stable virologic suppression. 
W. David Hardy, MD
Program Director
Princy N. Kumar, MD
person default
Jaimie P. Meyer, MD, MS, FACP
Babafemi Taiwo, MBBS
Physicians: maximum of 1.0 AMA PRA Category 1 Credit
Registered Nurses: 1.0 Nursing contact hour
Pharmacists: 1.0 contact hour (0.1 CEUs)
Released: June 18, 2018 Expiration: June 17, 2019

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Effectively integrate current data on PrEP for individuals at high risk for HIV infection
  • Effectively prevent or manage drug–drug interactions, adverse events, and other complications associated with HIV, antiretroviral therapy, and comorbidities including HCV infection
  • Evaluate the impact of opioid use disorder treatment on HIV treatment outcomes

Information on this Educational Activity

The Annenberg Center assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Program Director

W. David Hardy, MD

Adjunct Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland
Senior Director of Evidence-Based Practices
Whitman-Walker Health
Washington, DC

W. David Hardy, MD, has disclosed that he has received consulting fees from Gilead Sciences, Merck, and ViiV and funds for research support from Amgen, CytoDyn, Gilead Sciences, Janssen, Merck, and ViiV.

Faculty

Princy N. Kumar, MD

Professor of Medicine and Microbiology
Division of Infectious Diseases
Georgetown University Hospital
Division Chief
Division of Infectious Diseases and Travel Medicine
Department of Internal Medicine
Medstar Georgetown University Hospital
Washington, DC

Princy N. Kumar, MD, has disclosed that she has received consulting fees from Gilead Sciences, Theratechnologies, and ViiV Healthcare; has received funds for research support from Gilead Sciences, Merck, and ViiV; and has ownership interest in Gilead Sciences, Johnson & Johnson, Merck, and Pfizer.
Jaimie P. Meyer, MD, MS, FACP

Associate Professor of Medicine
AIDS Program
Section of Infectious Diseases
Yale School of Medicine
Clinical Assistant Professor of Medicine
Yale School of Nursing
New Haven, Connecticut

Jaimie P. Meyer, MD, MS, FACP, has disclosed that she has received funds for research support from and has served on an advisory board for Gilead Sciences.
Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Chief,
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Babafemi Taiwo, MBBS, has disclosed that he has received consulting fees from Gilead Sciences, GlaxoSmithKline, Janssen, Merck, and ViiV and funds for research support (paid to his institution) from GlaxoSmithKline and ViiV.

Staff

Jenny Schulz, PhD

Editorial Director, Virology & Other Therapeutic Areas

Jenny Schulz, PhD, has no real or apparent conflicts of interest to report.
Zachary Schwartz, MSc, ELS

Managing Editor

Zachary Schwartz, MSc, ELS, has no real or apparent conflicts of interest to report.
Megan Cartwright, PhD

Clinical Editor

Megan Cartwright, PhD, has no real or apparent conflicts of interest to report.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Charles W. Willis, MBA, Director of Continuing Education from the Annenberg Center for Health Sciences at Eisenhower receives consulting fees from Pfizer; Amanda Sewell, MBA, Manager of Continuing Education, and Alma Perez, Accreditation Specialist from the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Annenberg Center, Postgraduate Institute for Medicine (PIM), Clinical Care Options, and activity supporters do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Annenberg Center, PIM, Clinical Care Options, and activity supporters. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This program is intended for HIV specialists, infectious diseases clinicians, registered nurses, pharmacists, and other healthcare professionals involved in the care of patients with HIV infection.

Goal

The goal of this activity is to improve participants’ competence in addressing the most important and most current challenges in HIV management by providing a tightly focused update on recent advances and key clinical issues encountered in the clinic.

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Accreditation Statement

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Credit Designation

1.0 contact hour may be earned for successful completion of this activity.

Pharmacist Continuing Education

Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation

This program is assigned ACPE Universal Activity 0797-9999-18-074-H02-P. This program is designated for up to 1.0 contact hour (0.10 CEUs) of continuing pharmacy education credit.

Type of Activity Application

For Pharmacists: Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from June 18, 2018, through June 17, 2019:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME activities completed can be found on the "CME Manager" page. There are no costs/fees for this activity.

Related Content

Full slides: New data from International AIDS Conference (IAC) /AIDS 2018 in Amsterdam. From Eric S. Daar, MD, Joseph J. Eron, Jr., MD, Princy N. Kumar, MD

Eric S. Daar, MD Joseph J. Eron, Jr., MD Princy N. Kumar, MD Released: August 27, 2018

Expert commentary from Anton L. Pozniak, MD, FRCP, on how new data from AIDS 2018 will impact his treatment of HIV, as reported to Clinical Care Options (CCO).

Anton L. Pozniak, MD, FRCP Released: August 10, 2018

AIDS 2018: Slides from CCO’s official coverage of International AIDS Conference (IAC), as chosen by expert HIV faculty Eric Daar and Chloe Orkin.

Eric S. Daar, MD Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Released: August 9, 2018

Latest data from PARTNER2 study of HIV transmission between serodifferent MSM couples presented at AIDS 2018 and reported by Clinical Care Options.

Released: July 27, 2018

Acknowledgements

Jointly provided by Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC.
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Educational grants provided by
AbbVie
Gilead Sciences
Janssen Therapeutics
Merck & Co., Inc.
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?